BRCA2 and breast carcinoma: A variable that is somewhat connected to screening programs and might partially explain the country differences in incidence and survival is the prevalence of genetic mutations in populations; for example, mutations in BRCA 1 and BRCA2 tumor suppressor genes, which are significantly associated with the development of breast cancer by the age of 70 years [6].